NDC 0615-1338

Terazosin

Terazosin

Terazosin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. The primary component is Terazosin Hydrochloride.

Product ID0615-1338_8dcbb073-d3d6-4c00-9e59-6edb07d2c144
NDC0615-1338
Product TypeHuman Prescription Drug
Proprietary NameTerazosin
Generic NameTerazosin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1998-03-30
Marketing CategoryANDA / ANDA
Application NumberANDA074823
Labeler NameNCS HealthCare of KY, Inc dba Vangard Labs
Substance NameTERAZOSIN HYDROCHLORIDE
Active Ingredient Strength2 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 0615-1338-39

30 CAPSULE in 1 BLISTER PACK (0615-1338-39)
Marketing Start Date1998-03-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0615-1338-39 [00615133839]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA074823
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-03-30
Inactivation Date2020-01-31

NDC 0615-1338-31 [00615133831]

Terazosin CAPSULE
Marketing CategoryANDA
Application NumberANDA074823
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-03-01
Marketing End Date2015-05-19

Drug Details

Active Ingredients

IngredientStrength
TERAZOSIN HYDROCHLORIDE2 mg/1

OpenFDA Data

SPL SET ID:af1c3db8-940a-47bc-b30d-4ae428b9a029
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313217
  • 313219

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Terazosin" or generic name "Terazosin"

    NDCBrand NameGeneric Name
    0615-1338TerazosinTerazosin
    0615-1339TerazosinTerazosin
    10544-289TerazosinTerazosin
    23155-735terazosinterazosin
    23155-736terazosinterazosin
    23155-737terazosinterazosin
    23155-738terazosinterazosin
    33261-211TerazosinTerazosin
    33261-212TerazosinTerazosin
    33261-870TerazosinTerazosin
    42291-820TerazosinTerazosin Hydrochloride
    42291-821TerazosinTerazosin Hydrochloride
    42291-822TerazosinTerazosin Hydrochloride
    42291-823TerazosinTerazosin Hydrochloride
    50090-0657TerazosinTerazosin Hydrochloride
    50090-1559TerazosinTerazosin Hydrochloride
    50090-2371TerazosinTerazosin Hydrochloride
    50090-2623TerazosinTerazosin Hydrochloride
    50268-764TerazosinTerazosin Hydrochloride
    50268-765TerazosinTerazosin Hydrochloride
    50268-766TerazosinTerazosin Hydrochloride
    50268-767TerazosinTerazosin Hydrochloride
    51655-675TERAZOSINterazosin hydrochloride
    51655-676TERAZOSINterazosin hydrochloride
    70518-0342TerazosinTerazosin
    70518-0317TerazosinTerazosin
    70518-0074TerazosinTerazosin
    70518-1875TerazosinTerazosin
    53002-1250TerazosinTerazosin
    53002-1726TerazosinTerazosin
    53002-1727TerazosinTerazosin
    53002-1728TerazosinTerazosin
    53217-212TerazosinTerazosin
    53808-1056TerazosinTerazosin
    59746-383TerazosinTerazosin
    59746-384TerazosinTerazosin
    59746-386TerazosinTerazosin
    59746-385TerazosinTerazosin
    63187-456TerazosinTerazosin
    63187-620TerazosinTerazosin
    66267-325TerazosinTerazosin
    66267-389TerazosinTerazosin
    67296-1264TerazosinTerazosin
    55700-750TerazosinTerazosin
    71610-478TerazosinTerazosin
    0615-1337Terazosin HydrochlorideTerazosin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.